ArticleLancet regional health. Americas2026
Hepatitis C and risk of tuberculosis amongst United States veterans: a national cohort study.
Article in Lancet regional health. Americas, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculosis (TB) and hepatitis C virus (HCV) infections share many risk factors and settings. We sought to determine and compare the incidence of TB amongst HCV-positive and negative individuals in a large national cohort of United States veterans, controlling for multiple confounders. Methods: We conducted a retrospective-cohort study using data from The Electronically Retrieved Cohort of HCV-Infected Veterans (ERCHIVES) between 2001 and 2024 among United States veterans in care in the Veterans Affairs (VA) healthcare system. HCV-positive veterans were matched to HCV-negative veterans by age, sex, race/ethnicity, and VA enrollment year; veterans with TB diagnosed before the index HCV test, solid organ transplant history, and missing liver fibrosis score (FIB-4) or income data were excluded. Findings: The primary outcomes were incident TB, defined as a new diagnosis recorded in the electronic health record after the index HCV antibody test date. We also determined the risk of TB among HCV patients treated with and without sustained virologic response. In weighted multivariable analysis controlling for age, sex, income, fibrosis, smoking, homelessness, substance, alcohol, HIV, and other comorbidities, untreated HCV infection remained the greatest risk factor for TB (adjusted hazard ratio [aHR]: 1.67; 95% CI: 1.58-1.77) compared to HCV-negative individuals. Treated individuals with sustained virologic response (SVR) also had an increased TB risk (aHR: 1.26; 95% CI: 1.19-1.33), though less than untreated HCV. Treated individuals without SVR had a slightly lower TB risk (aHR: 1.56; 95% CI: 1.37-1.77), comparable to untreated HCV. Individuals with spontaneous viral clearance had similar risk for TB as treated individuals with SVR. (aHR: 1.28; 95% CI: 1.20-1.37). Interpretation: Our findings suggest people with HCV are at increased risk of tuberculosis, with decreasing risk among those successfully treated. This supports the need for comprehensive TB screening in individuals with HCV and the provision of early treatment for HCV with monitoring. Funding: This work was supported by resources and the use of facilities at the Veterans Health Administration (VA) Pittsburgh Healthcare System, and the central data repositories maintained by the VA Information Resource Center, including the National Patient Care Database, Decisions Support System Database, and Pharmacy Benefits Management Database.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.